» Articles » PMID: 38489395

Comparative Evaluation of Four Rapid Diagnostic Tests That Detect Human Trypanosoma Cruzi-specific Antibodies to Support Diagnosis of Chagas Disease in Urban Population of Argentina

Abstract

Background: Chagas disease (CD), caused by the parasite Trypanosoma cruzi, is the most important endemic anthropozoonosis in Argentina. Since 2010, the World Health Organization has highlighted the urgent need to validate diagnostic systems that allow rapid detection of T. cruzi, infection in primary healthcare centers. Serological rapid diagnostic tests (RDTs) for T. cruzi, infection could be used to improve case management, as RDTs do not require specialized laboratories or highly trained staff to use them. We aimed to generate unbiased performance data of RDTs in Argentina, to evaluate their usefulness for improving T. cruzi, diagnosis rates.

Methods And Principal Findings: This is a retrospective, laboratory-based, diagnostic evaluation study to estimate the clinical sensitivity/specificity of four commercially available RDTs for T. cruzi, using the Chagas disease diagnostic algorithm currently used in Argentina as the reference standard. In total, 400 serum samples were tested, 200 from individuals with chronic T. cruzi infection and 200 from individuals not infected with T. cruzi. All results were registered as the agreement of at least two operators who were blinded to the reference standard results. The sensitivity estimates ranged from 92.5-100% (95% confidence interval (CI) lower bound 87.9-98.2%); for specificity, the range was 76-96% (95% CI lower bound 69.5-92.3%). Most RDTs evaluated showed performances comparable with the reference standard method, showing almost perfect concordance (Kappa 0.76-0.92).

Conclusions: Our study demonstrates that, under controlled laboratory conditions, commercially available RDTs for CD have a performance comparable to the Argentinian diagnostic algorithm, which is based on laboratory-based serological tests. For the next stage of our work, the RDTs will be evaluated in real-world settings.

Citing Articles

Oral Chagas disease outbreak by bacaba juice ingestion: A century after Carlos Chagas' discovery, the disease is still hard to manage.

Simoes-Neto E, Wagner de Castro Lima Santos D, Bomfim M, Costa J, Simoes A, Vasconcelos L PLoS Negl Trop Dis. 2024; 18(9):e0012225.

PMID: 39292716 PMC: 11441692. DOI: 10.1371/journal.pntd.0012225.


Recombinant proteins as promising antigens applied to the immunodiagnosis of Chagas disease: a scoping review.

Resende C, Ribeiro A, Gandra I, Silva K, Lopes L, Barcelos I Front Microbiol. 2024; 15:1420226.

PMID: 39139374 PMC: 11319188. DOI: 10.3389/fmicb.2024.1420226.


diagnostic methods of Chagas disease in the clinical laboratory: a scoping review.

Ascanio L, Carroll S, Paniz-Mondolfi A, Ramirez J Front Microbiol. 2024; 15:1393992.

PMID: 38746745 PMC: 11091413. DOI: 10.3389/fmicb.2024.1393992.

References
1.
Souza R, Gorla D, Chame M, Jaramillo N, Monroy C, Diotaiuti L . Chagas disease in the context of the 2030 agenda: global warming and vectors. Mem Inst Oswaldo Cruz. 2022; 117:e200479. PMC: 9150778. DOI: 10.1590/0074-02760200479. View

2.
Coura J, Albajar Vinas P . Chagas disease: a new worldwide challenge. Nature. 2010; 465(7301):S6-7. DOI: 10.1038/nature09221. View

3.
Sanchez-Camargo C, Albajar-Vinas P, Wilkins P, Nieto J, Leiby D, Paris L . Comparative evaluation of 11 commercialized rapid diagnostic tests for detecting Trypanosoma cruzi antibodies in serum banks in areas of endemicity and nonendemicity. J Clin Microbiol. 2014; 52(7):2506-12. PMC: 4097696. DOI: 10.1128/JCM.00144-14. View

4.
Bermejo-Pelaez D, San Jose Estepar R, Fernandez-Velilla M, Palacios Miras C, Gallardo Madueno G, Benegas M . Deep learning-based lesion subtyping and prediction of clinical outcomes in COVID-19 pneumonia using chest CT. Sci Rep. 2022; 12(1):9387. PMC: 9172615. DOI: 10.1038/s41598-022-13298-8. View

5.
Angheben A, Buonfrate D, Cruciani M, Jackson Y, Alonso-Padilla J, Gascon J . Rapid immunochromatographic tests for the diagnosis of chronic Chagas disease in at-risk populations: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2019; 13(5):e0007271. PMC: 6561601. DOI: 10.1371/journal.pntd.0007271. View